ANTITHROMBIN III HUMAN for Abnormal clotting factor: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where ANTITHROMBIN III HUMAN was used for Abnormal clotting factor.
Most Reported Side Effects for ANTITHROMBIN III HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 19 | 20.7% | 5 | 12 |
| Off label use | 17 | 18.5% | 1 | 4 |
| Contraindicated product administered | 11 | 12.0% | 1 | 0 |
| Prescribed overdose | 11 | 12.0% | 1 | 0 |
| Foetal exposure during pregnancy | 9 | 9.8% | 1 | 0 |
| Hepatic function abnormal | 7 | 7.6% | 0 | 7 |
| Hyperglycaemia | 7 | 7.6% | 0 | 7 |
| Premature baby | 7 | 7.6% | 0 | 0 |
| Adenovirus infection | 5 | 5.4% | 0 | 5 |
| Cholestasis | 5 | 5.4% | 0 | 5 |
| Diarrhoea | 5 | 5.4% | 0 | 5 |
| Graft versus host disease | 5 | 5.4% | 0 | 5 |
| Ileus paralytic | 5 | 5.4% | 0 | 5 |
| Low birth weight baby | 5 | 5.4% | 0 | 1 |
| Maternal exposure during pregnancy | 5 | 5.4% | 0 | 3 |
Other Indications for ANTITHROMBIN III HUMAN
Prophylaxis (14)
Anticoagulant therapy (12)
Antithrombin iii deficiency (9)
Product used for unknown indication (6)
Foetal exposure during pregnancy (5)
Thrombosis prophylaxis (5)